Candel Therapeutics, Inc. (CADL) Ownership

$5.79

$0.03 (-0.52%)
Last update: 04:00 PM EST
Day's range
$5.7
Day's range
$5.92

Candel Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/14/2025 8.23 M $41.66 M   16.20% 25.99%
08/14/2025 2.58 M $13.06 M   19.90% 8.15%
BLACKROCK, INC. 08/12/2025 2.30 M $11.65 M   30.51% 7.27%
VANGUARD GROUP INC 08/11/2025 1.79 M $9.04 M   2.96% 5.64%
PORTOLAN CAPITAL MANAGEMENT, LLC 08/13/2025 1.62 M $8.21 M   84.04% 5.12%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 903.97 K $4.57 M   31.49% 2.85%
HALTER FERGUSON FINANCIAL INC. 07/11/2025 776.52 K $3.93 M   12.03% 2.45%
STATE STREET CORP 08/14/2025 651.98 K $3.30 M   15.72% 2.06%
SANDS CAPITAL VENTURES, LLC 08/13/2025 405.84 K $2.05 M   0.00% 1.28%
TWO SIGMA INVESTMENTS, LP 08/14/2025 369.20 K $1.87 M   100.00% 1.17%
BAKER BROS. ADVISORS LP 08/14/2025 355.11 K $1.80 M   -85.43% 1.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 353.30 K $1.79 M   46.49% 1.12%
CITADEL ADVISORS LLC 08/14/2025 306.00 K $1.55 M   13.12% 0.97%
NORTHERN TRUST CORP 08/13/2025 287.86 K $1.46 M   22.22% 0.91%
TANAGER WEALTH MANAGEMENT LLP 07/18/2025 196.63 K $994.95 K   100.00% 0.62%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 164.90 K $834.39 K   -34.85% 0.52%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 163.60 K $827.82 K   100.00% 0.52%
MARSHALL WACE, LLP 08/13/2025 161.48 K $817.09 K   -31.17% 0.51%
JANE STREET GROUP, LLC 08/14/2025 146.30 K $740.28 K   160.78% 0.46%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 117.90 K $596.57 K   -43.78% 0.37%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 113.77 K $575.69 K   35.64% 0.36%
MORGAN STANLEY 08/15/2025 113.72 K $575.43 K   82.03% 0.36%
08/12/2025 92.48 K $467.96 K   18.35% 0.29%
BANK OF NEW YORK MELLON CORP 08/05/2025 86.80 K $439.23 K   42.87% 0.27%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2025 86.25 K $436.41 K   100.00% 0.27%
UBS GROUP AG 08/14/2025 82.17 K $415.77 K   -56.08% 0.26%
COMMONWEALTH EQUITY SERVICES, LLC 08/06/2025 81.60 K $413.00 K   25.40% 0.26%
GOLDMAN SACHS GROUP INC 08/14/2025 79.41 K $401.79 K   45.25% 0.25%
XTX TOPCO LTD 08/12/2025 74.63 K $377.62 K   100.00% 0.24%
BANK OF AMERICA CORP /DE/ 08/14/2025 73.12 K $370.00 K   -59.21% 0.23%
ALLIANCEBERNSTEIN L.P. 08/14/2025 69.11 K $349.70 K   548.31% 0.22%
BARCLAYS PLC 08/14/2025 68.44 K $346.00 K   118.49% 0.22%
LPL FINANCIAL LLC 08/12/2025 67.89 K $343.54 K   100.00% 0.21%
BIRCHVIEW CAPITAL, LP 08/14/2025 60.00 K $303.60 K   0.00% 0.19%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2025 55.10 K $278.81 K   100.00% 0.17%
RHUMBLINE ADVISERS 08/12/2025 54.50 K $275.75 K   63.65% 0.17%
MONETA GROUP INVESTMENT ADVISORS LLC 08/14/2025 40.52 K $205.02 K   4.24% 0.13%
CITADEL ADVISORS LLC 08/14/2025 37.60 K $190.26 K   -21.50% 0.12%
SQUAREPOINT OPS LLC 08/27/2025 36.95 K $186.97 K   -50.78% 0.12%
TWO SIGMA ADVISERS, LP 08/14/2025 36.49 K $184.61 K   100.00% 0.12%
CUBIST SYSTEMATIC STRATEGIES, LLC 08/14/2025 28.48 K $144.08 K   100.00% 0.09%
JANNEY MONTGOMERY SCOTT LLC 07/17/2025 27.29 K $138.00 K   29.40% 0.09%
ALPS ADVISORS INC 08/11/2025 27.05 K $136.85 K   100.00% 0.09%
METLIFE INVESTMENT MANAGEMENT, LLC 08/13/2025 25.55 K $129.26 K   67.77% 0.08%
LOS ANGELES CAPITAL MANAGEMENT LLC 08/07/2025 24.81 K $125.54 K   100.00% 0.08%
INTECH INVESTMENT MANAGEMENT LLC 08/08/2025 23.87 K $120.79 K   -16.44% 0.08%
STRATOS WEALTH ADVISORS, LLC 07/29/2025 23.00 K $116.38 K   0.00% 0.07%
RAYMOND JAMES FINANCIAL INC 08/14/2025 22.16 K $112.15 K   -2.15% 0.07%
DEUTSCHE BANK AG\ 08/12/2025 21.63 K $109.42 K   -17.50% 0.07%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 08/14/2025 21.52 K $108.89 K   28.49% 0.07%

Candel Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 95 institutional investors and hedge funds held shares of Candel Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 8.23 M

BlackRock, Inc.: 2.3 M

VANGUARD GROUP INC: 1.79 M

Portolan Capital Management, LLC: 1.62 M

GEODE CAPITAL MANAGEMENT, LLC: 903,970

Halter Ferguson Financial Inc.: 776,516

72.70% of Candel Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 23.24 M shares in the last 24 months. This purchase volume represents approximately $134.53 M in transactions.